Healthcare - Biotechnology - NASDAQ - NL
$ 20.35
-0.973 %
$ 1.1 B
Market Cap
-7.37
P/E
Price Target
Average
79.71%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
44.12%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Pharvaris N.V.
Wall Street analysts predict an average 1-year price target for PHVS of $36.6 , with forecasts ranging from a low of $22 to a high of $50 .
PHVS Lowest Price Target
Wall Street Target
22 USD
8.11%
PHVS Average Price Target
Wall Street Target
36.6 USD
79.71%
PHVS Highest Price Target
Wall Street Target
50 USD
145.70%
REVENUE FORECAST
Revenue Forecast Chart PHVS
EBIT FORECAST
EBIT Forecast Chart PHVS
NET INCOME FORECAST
Net Income Chart PHVS